vimarsana.com

Latest Breaking News On - நுரையீரல் புற்றுநோய் முயற்சி - Page 4 : vimarsana.com

Roundup: NHS trust introduces translation tech, AI based cough analyser in Spanish and more briefs

NHS TRUST INTRODUCES TRANSLATION TECH Kettering General Hospital NHS FT has begun using a live translation service within its video consultation platform to improve accessibility for non-English-speaking patients. The move will also allow the trust to make up to 90% cost-savings on traditional translation services. The trust deployed the eClinic video consultation platform from the patient communications provider, Healthcare Communications, in August 2020 to reduce the number of patients visiting the hospital during the pandemic. The platform integrates with the trust’s patient administration system (PAS) and enables patients to attend appointments remotely on a browser, using a smartphone, laptop or tablet.

Inivata s Liquid Biopsy Technology Included in Unique £10m Research Collaboration for Early Detection of Lung Cancer

News Category Global Banking & Finance Reviews Inivata’s Liquid Biopsy Technology Included in Unique £10m Research Collaboration for Early Detection of Lung Cancer Inivata’s Liquid Biopsy Technology Included in Unique £10m Research Collaboration for Early Detection of Lung Cancer Research Collaboration to be led by the University of Southampton and along with several major diagnostics and informatics companies will test the best way of detecting cancers at a stage when they can still be cured Inivata’s InVision Liquid Biopsy platform will be used to detect mutations in ctDNA in study participants Research Triangle Park, NC, USA and Cambridge, UK, 18 December 2020 – Inivata, a leader in liquid biopsy, today announces its participation in a major research collaboration to investigate integrated diagnostics for the early detection of lung cancer with the aim of increasing survival rates, alongside improving the efficiency of testing in people at high risk of cancer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.